Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 12/20 | 0.57 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.57 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.57 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5689598 | 1.00 | GRIN2B (0.57) | GRIN2BSIGMAR1GRIN1SPHK1OPRM1 | |
| SCHEMBL5689576 | 0.90 | GRIN2B (0.65) | GRIN2BSIGMAR1GRIN1SPHK1OPRM1 | |
| SCHEMBL5689642 | 0.90 | GRIN2B (0.65) | GRIN2BSIGMAR1GRIN1SPHK1OPRM1 | |
| SCHEMBL5689574 | 0.90 | GRIN2B (0.65) | GRIN2BSIGMAR1GRIN1SPHK1OPRM1 | |
| SCHEMBL5689946 | 0.86 | GRIN2B (0.61) | GRIN2BSIGMAR1GRIN1SPHK1 | |
| SCHEMBL5689944 | 0.86 | GRIN2B (0.61) | GRIN2BSIGMAR1GRIN1SPHK1 | |
| SCHEMBL5690203 | 0.86 | GRIN2B (0.61) | GRIN2BSIGMAR1GRIN1SPHK1 | |
| Hydrochloric Acid SCHEMBL5691921 | 0.85 | GRIN2B (0.60) | GRIN2BSIGMAR1GRIN1SPHK1OPRM1 | |
| Hydrochloric Acid SCHEMBL5691923 | 0.85 | GRIN2B (0.60) | GRIN2BSIGMAR1GRIN1SPHK1OPRM1 | |
| SCHEMBL5689782 | 0.82 | GRIN2B (0.62) | GRIN2BSIGMAR1GRIN1SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0982026-B1 | Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers | HOFFMANN LA ROCHE (CH) | 2006-05-17 | — | — | EP | disclosed |
| US-6184236-B1 | Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative | HOFFMANN-LA ROCHE INC. | 2001-02-06 | — | — | US | disclosed |
| EP-0982026-A2 | Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers | F. HOFFMANN-LA ROCHE AG (CH) | 2000-03-01 | — | — | EP | disclosed |